Effectiveness of high-dose steroid treatment on pulmonary fibrosis in severe COVID-19 pneumonia

Gülhan AYHAN ALBAYRAK; Müfide Arzu Özkarafakılı

doi:10.32322/jhsm.1785790

January 5, 2026Journal of Health Sciences and MedicineOpen Access

Effectiveness of high-dose steroid treatment on pulmonary fibrosis in severe COVID-19 pneumonia

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the effects of high-dose steroid treatment on pulmonary fibrosis in severe COVID-19 pneumonia patients.
Retrospective analysis of hospitalized patients with severe COVID-19 pneumonia
Patients categorized into groups receiving methylprednisolone, dexamethasone, or control treatment
Clinical, demographic, and laboratory data analysis alongside chest CT assessments
70.8% of patients treated with methylprednisolone showed radiological improvement
58.5% of patients treated with dexamethasone showed radiological improvement
The control group showed less improvement at 35.4%

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Retrospective study shows improved clinical outcomes with high-dose dexamethasone in COVID-19 pneumonia patients, indicating corticosteroids may aid recovery.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

ALBAYRAK et al. (2026) studied this question.

synapsesocial.com/papers/6966e6f513bf7a6f02bfefb1 https://doi.org/10.32322/jhsm.1785790

View Full Paper

Ask AI

Bookmark

Share

Effectiveness of high-dose steroid treatment on pulmonary fibrosis in severe COVID-19 pneumonia

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Effectiveness of high-dose steroid treatment on pulmonary fibrosis in severe COVID-19 pneumonia

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

More related papers

More from Journal of Health Sciences and Medicine

Keep reading

More related papers

More from Journal of Health Sciences and Medicine